Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Renner

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Virology|April 20, 2007
Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectorsMatthias Paar, Sonja Schwab, Doris Rosenfellner, et al.
The CRISPR Journal|April 22, 2022
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal ProductsBrigitte Anliker, Liam Childs, Juliane Rau, et al.
Biochemical Pharmacology|August 5, 2006
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapyJohannes Lengler, Markus Omann, Dana Düvier, et al.
Cell Stem Cell|October 7, 2017
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk AssessmentMohamed Abou-El-Enein, Toni Cathomen, Zoltán Ivics, et al.
Plos One|July 21, 2012
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerJuraj Hlavaty, Helga Petznek, Harry Holzmüller, et al.
Advances in Experimental Medicine and Biology|September 17, 2015
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT PerspectivePaula Salmikangas, Martina Schuessler-Lenz, Sol Ruiz, et al.
Virology|August 2, 2005
Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectorsJuraj Hlavaty, Matthias Schittmayer, Anika Stracke, et al.
Histochemistry and Cell Biology|April 12, 2017
Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo studyJuraj Hlavatý, Zbyněk Tonar, Matthias Renner, et al.
Human Gene Therapy. Clinical Development|July 19, 2013
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesisAlessandro Aiuti, Giulio Cossu, Pablo de Felipe, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 13, 2002
A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II studyStanislaw Winiarczyk, Zbigniew Gradski, Barbara Kosztolich, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Virology|April 20, 2007
Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectorsMatthias Paar, Sonja Schwab, Doris Rosenfellner, et al.
The CRISPR Journal|April 22, 2022
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal ProductsBrigitte Anliker, Liam Childs, Juliane Rau, et al.
Biochemical Pharmacology|August 5, 2006
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapyJohannes Lengler, Markus Omann, Dana Düvier, et al.
Cell Stem Cell|October 7, 2017
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk AssessmentMohamed Abou-El-Enein, Toni Cathomen, Zoltán Ivics, et al.
Plos One|July 21, 2012
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerJuraj Hlavaty, Helga Petznek, Harry Holzmüller, et al.
Advances in Experimental Medicine and Biology|September 17, 2015
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT PerspectivePaula Salmikangas, Martina Schuessler-Lenz, Sol Ruiz, et al.
Virology|August 2, 2005
Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectorsJuraj Hlavaty, Matthias Schittmayer, Anika Stracke, et al.
Histochemistry and Cell Biology|April 12, 2017
Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo studyJuraj Hlavatý, Zbyněk Tonar, Matthias Renner, et al.
Human Gene Therapy. Clinical Development|July 19, 2013
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesisAlessandro Aiuti, Giulio Cossu, Pablo de Felipe, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 13, 2002
A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II studyStanislaw Winiarczyk, Zbigniew Gradski, Barbara Kosztolich, et al.
Pageof 4